Vol 12, No 4 (2016)

Date published: 2016-12-22

Table of Contents

open access

REVIEW ARTICLES

Side effects of tyrosine kinase inhibitors — management guidelines

Adam Płużański, Aleksandra Piórek

Review paper

DOI: 10.5603/OCP.2016.0004
Oncol Clin Pract 2016;12(4):113-118.

Nadroparin in the prophylaxis and treatment of thromboembolic complications in cancer patients

Marek Z. Wojtukiewicz, Piotr Skalij, Piotr Tokajuk

Review paper

DOI: 10.5603/OCP.2016.0001
Oncol Clin Pract 2016;12(4):119-127.

The use of antibiotic prophylaxis in patients with solid tumours — when and to whom?

Joanna Kardas, Agnieszka Buraczewska

Review paper

DOI: 10.5603/OCP.2016.0005
Oncol Clin Pract 2016;12(4):128-135.

Bevacizumab — cardiovascular side effects in daily practice

Tomasz Lewandowski, Sebastian Szmit

Review paper

DOI: 10.5603/OCP.2016.0003
Oncol Clin Pract 2016;12(4):136-143.

Recent changes on the biopharmaceutical market after the introduction of biosimilar G-CSF products

Joanna Zielińska, Włodzimierz Bialik

Review paper

DOI: 10.5603/OCP.2016.0006
Oncol Clin Pract 2016;12(4):144-152.

Prevention of chemotherapy-induced nausea and vomiting — standards versus clinical practice

Adam Płużański, Ewa Kalinka-Warzocha, Aleksandra Łacko, Maryna Rubach

Review paper

DOI: 10.5603/OCP.2016.0002
Oncol Clin Pract 2016;12(4):153-157.
CONGRESS REPORT

ESMO Congress 2016: Three of the most important studies in the field of breast cancer

Dorota Kwapisz

Congress abstract / Abstract

DOI: 10.5603/OCP.2016.0007
Oncol Clin Pract 2016;12(4):158-160.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl